ASDAS states in patients stratified by baseline MRI/CRP status.

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies, Arthritis Research & Therapy

JCM, Free Full-Text

Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association

ASDAS-MI responder rates at week 52 stratified by baseline MRI/CRP status

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

Disease stratification in GCA and PMR: state of the art and future perspectives

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

Optimizing multi-domain hematologic biomarkers and clinical features for the differential diagnosis of unipolar depression and bipolar depression

Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers - Liu - 2023 - Journal of Internal Medicine - Wiley Online Library

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Machine Learning for Prediction of Adverse Cardiovascular Events in Adults With Repaired Tetralogy of Fallot Using Clinical and Cardiovascular Magnetic Resonance Imaging Variables